Waseem AlZamzami | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Waseem AlZamzami | Medicine and Dentistry | Best Researcher Award

University of Tabuk, Saudi Arabia

Assoc. Prof. Dr. Waseem A. AlZamzami is an accomplished researcher and academic in hematopathology, molecular hematology, and cancer biology, with a strong focus on genomics, transcriptomics, metabolomics, and bioinformatics. He earned his Ph.D. in Clinical Laboratory Science from The Catholic University of America, Washington DC (2015–2022), following an M.S. in Health Sciences from Quinnipiac University, Connecticut (2013–2015), and a B.Sc. in Laboratory Medicine from Umm Al-Qurra University, Saudi Arabia (2002–2006). His professional journey includes extensive research training at the National Cancer Institute/National Institutes of Health (NCI/NIH), Bethesda, USA, where he contributed to advancing cancer genetics and translational hematology. Currently serving as an Assistant Professor of Hematology at the University of Tabuk, Saudi Arabia, he has held multiple leadership roles such as Committee Chairman for Laboratory Management, Unit Chairman for Measurement and Evaluation, and active member of Accreditation, Quality Assurance, and Curriculum Development committees. His research interests center on genetic screening, biomarker discovery, and integration of multi-omics to drive precision oncology and personalized treatment strategies. Dr. AlZamzami has authored publications in reputed journals including Discovery Medicine, Molecular Syndromology, PLOS ONE, and Cancers, with a Scopus record of 9 documents, 36 citations, and an h-index of 3, alongside three recent Saudi patents in hematological malignancies and cancer genomics. He is also a dedicated reviewer for journals such as PLOS ONE, Process Biochemistry, and International Immunopharmacology. His research skills span molecular diagnostics, bioinformatics, laboratory medicine, multi-omics analysis, and translational applications bridging bench to bedside. Recognized through international symposium presentations at NIH and national scientific forums, he has also contributed to scientific community development by mentoring students and organizing academic events. In conclusion, Dr. Waseem A. AlZamzami exemplifies a distinguished researcher whose academic excellence, innovative research, and leadership contributions to cancer biology and hematology strongly position him as a driving force in advancing precision medicine and biomedical research globally.

Profile: Scopus |ORCID| Google Scholar

Featured Publications

  1. Yan, H., Malik, N., Kim, Y. I., He, Y., Li, M., Dubois, W., Liu, H., Peat, T. J., Nguyen, J. T., … (2021). Fatty acid oxidation is required for embryonic stem cell survival during metabolic stress. EMBO Reports, 22(6), e52122.

  2. Oyouni, A. A. A., Al-Amer, O. M., Ali, F. A. Z., Altayar, M. A., Jalal, M. M., Albalawi, R. S. M., … (2022). Melatonin ameliorates the adrenal and pancreatic alterations in streptozotocin-induced diabetic rats: Clinical, biochemical, and descriptive histopathological studies. Frontiers in Veterinary Science, 9, 1016312.

  3. Seshadri, V. D., Oyouni, A. A. A., Hawsawi, Y. M., Aljohani, S. A. S., Al-Amer, O. M., … (2022). Chemopreventive role of Tin oxide–Chitosan–Polyethylene glycol–Crocin nanocomposites against lung cancer: An in vitro and in vivo approach. Process Biochemistry, 120, 186–194.

  4. Al-Amer, O. M., Mir, R., Hamadi, A., Alasseiri, M. I., Altayar, M. A., AlZamzami, W., … (2023). Antiapoptotic gene genotype and allele variations and the risk of lymphoma. Cancers, 15(4), 1012.

  5. Vijayaragavan, P., Rathi, M. A., Gopalakrishnan, V. K., Pashameah, R. A., … (2022). CpG methylation analysis of tumour suppressor gene and expression of cathepsin B in renal cell carcinoma. Journal of King Saud University – Science, 34(8), 102330.

Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Dr. Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Mary Bird Perkins Cancer Center | United States

Dr. Sotirios Stathakis is an accomplished medical physicist with extensive experience in radiation oncology, advanced treatment planning, and patient safety in cancer care. Currently serving as the Chief of Physics at Mary Bird Perkins Cancer Center and Adjunct Professor at Louisiana State University, he has established himself as a leader in both clinical and academic domains. His work bridges fundamental research and real-world clinical application, focusing on improving the accuracy, efficiency, and safety of radiotherapy treatments. With a career spanning over two decades, Dr. Stathakis has played a pivotal role in advancing technologies such as intensity-modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), Monte Carlo simulations, and adaptive radiotherapy. He has supervised graduate students, medical residents, and postdoctoral fellows, contributing to the development of the next generation of medical physicists. Dr. Stathakis is internationally recognized for his innovative contributions to medical physics, publishing widely in peer-reviewed journals and presenting at global conferences. His leadership in quality assurance (QA) protocols, radiotherapy safety standards, and patient-centered innovations has earned him professional recognition as a Fellow of the American Association of Physicists in Medicine (AAPM). He continues to expand his research by integrating artificial intelligence, patient education, and wearable technology into cancer care.

Professional Profile

Scopus | ORCID

Education

Dr. Sotirios Stathakis has a strong academic background rooted in physics and medical physics, which forms the foundation of his distinguished career in cancer treatment and research. He began his academic journey with a Bachelor of Science in Physics from the University of Waterloo, Canada, where he developed a strong foundation in core physical sciences and problem-solving skills. Driven by an interest in applying physics to medicine, he pursued a Master of Science in Medical Physics at the University of Aberdeen, United Kingdom. Here, he received specialized training in radiological sciences, medical imaging, and radiotherapy applications, which fueled his passion for research in patient care. His academic progression culminated in a Ph.D. in Medical Physics from the University of Patras, Greece, where his doctoral work focused on advanced radiation dosimetry and optimization of treatment planning systems. His doctoral training allowed him to explore Monte Carlo simulations and radiation safety protocols, which later became key aspects of his professional contributions. This comprehensive education, spanning North America and Europe, equipped him with a unique global perspective and multidisciplinary expertise. It also prepared him to integrate clinical practice with research, ultimately shaping his career as a recognized leader in medical physics and radiation oncology.

Professional Experience

Dr. Sotirios Stathakis has accumulated diverse professional experience that reflects his dual commitment to academic research and clinical application. He began his career in Europe, contributing to medical physics research before moving to the United States, where he established himself in leading academic and clinical institutions. At the University of Texas Health Science Center San Antonio (UTHSA), he served as a Professor and Medical Physicist, taking on responsibilities that included treatment planning, clinical implementation of new radiotherapy techniques, and the supervision of graduate students and medical residents. His academic contributions included teaching advanced courses in radiation oncology physics and mentoring Ph.D. dissertations. He later transitioned to his current role as Chief of Physics at Mary Bird Perkins Cancer Center, where he oversees medical physics operations across multiple oncology centers. In this role, he leads a team of physicists and ensures the safe and effective delivery of radiation treatments to cancer patients. His position as Adjunct Professor at Louisiana State University complements his clinical work, as he continues to teach and mentor the next generation of medical physicists. Throughout his career, Dr. Stathakis has balanced leadership, clinical service, and research, contributing to advancements in both patient care and academic knowledge.

Research Interests

Dr. Sotirios Stathakis’s research interests lie at the intersection of clinical innovation, radiation therapy optimization, and patient-centered approaches. A central focus of his research is the improvement of treatment planning systems, particularly through advanced modeling such as Monte Carlo simulations, which enhance accuracy in dose calculations. He has contributed to the development and refinement of quality assurance (QA) protocols, ensuring precision in intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT). Another important area of his research includes studying the secondary cancer risks associated with radiotherapy, providing valuable insights into long-term patient safety. Dr. Stathakis is also exploring the role of artificial intelligence (AI) in radiotherapy, particularly for dose prediction and workflow optimization, which has the potential to revolutionize clinical practices. In recent years, he has expanded his focus to include patient-centered technologies, such as wearable monitoring devices and virtual reality tools that improve patient education, engagement, and treatment compliance. His interdisciplinary approach combines physics, engineering, computer science, and clinical oncology, creating innovative solutions to complex healthcare challenges. By bridging these fields, Dr. Stathakis continues to advance the standards of radiotherapy, contributing to safer, more effective, and personalized cancer treatments.

Research Skills

Dr. Sotirios Stathakis possesses a broad range of research skills that span computational modeling, experimental validation, clinical trial design, and academic mentoring. His expertise in Monte Carlo simulations allows him to perform highly accurate radiation dose calculations, a critical aspect of treatment planning and safety assessment in radiation oncology. He is also highly skilled in advanced quality assurance techniques, particularly for IMRT and VMAT, ensuring reliable and precise delivery of radiation therapy. Dr. Stathakis is proficient in using and commissioning treatment planning systems and linear accelerators, applying both theoretical and practical approaches to improve clinical workflows. His research methodology incorporates statistical analysis, machine learning, and artificial intelligence, enabling him to address complex problems in treatment optimization and patient safety. Beyond technical skills, he excels in collaborative project management, coordinating interdisciplinary teams across physics, medicine, and engineering. His experience extends to academic publishing, peer review, and conference presentations, reflecting his ability to effectively disseminate scientific findings. As a mentor and educator, he has guided Ph.D. students and medical residents in developing independent research projects, further demonstrating his leadership in research environments. Collectively, these skills highlight his ability to translate advanced scientific concepts into practical innovations that benefit cancer patients worldwide.

Awards and Honors

Throughout his career, Dr. Sotirios Stathakis has received numerous awards and honors in recognition of his academic excellence, clinical leadership, and professional service. One of the most prestigious distinctions in his career is being named a Fellow of the American Association of Physicists in Medicine (AAPM), a recognition reserved for members who have made significant contributions to the advancement of medical physics. He is also board-certified in Therapeutic Radiologic Physics by the American Board of Radiology (ABR), underscoring his professional expertise and credibility in clinical practice. His academic work has been acknowledged through invitations to present at leading international conferences, including those organized by IEEE, AAPM, and ESTRO, where he has shared groundbreaking findings on radiotherapy optimization and quality assurance. In addition, Dr. Stathakis has served as a peer reviewer for high-impact journals such as the Journal of Applied Clinical Medical Physics (JACMP), further highlighting his standing in the scientific community. He has also been recognized by institutions where he has taught and worked, receiving commendations for excellence in mentorship and clinical service. These honors reflect his consistent commitment to innovation, patient safety, and education, solidifying his reputation as a respected leader in medical physics and radiation oncology.

Publication Top Notes

  • AAPM TG report 312: Acceptance testing, commissioning, and periodic quality assurance of ion chamber and diode detector arrays — 2025

  • Dosimetric characterization of a new surface-conforming electron MLC prototype — 2024 — 1 citation

  • Monte Carlo modeling of the Elekta Versa HD and patient dose calculation with EGSnrc/BEAMnrc — 2022 — 5 citations

  • Erratum to: Report of AAPM Task Group 219 on independent calculation-based dose/MU verification for IMRT — 2021

  • Artificial intelligence based deconvolving on megavoltage photon beam profiles for radiotherapy applications — 2022

  • A customizable aluminum compensator system for total body irradiation — 2021

Conclusion

Dr. Sotirios Stathakis’s career represents a remarkable combination of academic excellence, clinical innovation, and professional leadership. His work has transformed multiple aspects of radiation oncology, from enhancing treatment planning accuracy to implementing robust quality assurance protocols that safeguard patient outcomes. With a strong foundation in education from top institutions across Canada, the United Kingdom, and Greece, coupled with his leadership roles in the United States, he exemplifies the global nature of medical physics. His research interests and skills reflect both scientific rigor and compassion, as he continually integrates patient-centered approaches into his innovations. Recognized internationally through awards, honors, and professional certifications, Dr. Stathakis has established himself as a trusted authority in his field. His mentorship of students and collaboration with clinicians ensure that his influence extends beyond his individual achievements, shaping the future of cancer care. Looking ahead, his engagement with artificial intelligence, wearable technology, and advanced radiotherapy models positions him to make further groundbreaking contributions. In sum, Dr. Stathakis embodies the qualities of a dedicated researcher, educator, and clinician, making him not only a leader in medical physics but also a driving force in advancing the fight against cancer globally.

Suvi M Virtanen | Medicine and Dentistry | Best Researcher Award

Prof Dr. Suvi M Virtanen | Medicine and Dentistry | Best Researcher Award

Research Professor, Finnish Institute for Health and Welfare , Finland

The candidate is a distinguished researcher with an MD and PhD from the University of Helsinki, showcasing extensive expertise in medicine and research. Currently serving as a Research Professor at the Finnish Institute for Health and Welfare and a Professor of Epidemiology at Tampere University, the candidate has demonstrated outstanding leadership in public health and nutrition research. Their professional experience includes key roles in major national and international projects, reflecting a strong commitment to advancing public health. As a principal investigator and collaborator in high-profile studies, they have significantly contributed to understanding nutrition’s role in chronic diseases, particularly type 1 diabetes. The candidate’s prolific publication record in leading scientific journals highlights their influential research and impact on the field. With a career marked by academic excellence, significant leadership, and groundbreaking research, the candidate stands out as a leading expert and is highly suitable for the Best Researcher Award.

 

Profile:

Education

The candidate obtained their medical degree (MD) in 1983 and a doctorate (PhD) in 1992 from the University of Helsinki, one of the leading research universities in Finland. Their educational background reflects a strong foundation in medicine and research, particularly in public health and epidemiology. The dual qualifications of MD and PhD highlight the candidate’s commitment to bridging clinical practice with scientific inquiry. Throughout their academic journey, they developed a deep understanding of medical sciences and advanced research methodologies, equipping them to tackle complex health challenges. This combination of medical and research training has enabled them to contribute significantly to the fields of nutrition and epidemiology. Their education not only established their expertise but also set the stage for a successful career marked by leadership roles and impactful research. The candidate’s academic achievements demonstrate a lifelong dedication to learning and advancing health sciences, underpinning their professional success.

 

Professional Experiences 

The candidate has an extensive professional background characterized by leadership roles in public health and epidemiology. Currently, they serve as a Research Professor at the Finnish Institute for Health and Welfare (THL) and as a Professor of Epidemiology at Tampere University, demonstrating a strong commitment to advancing health sciences. They also manage projects related to child health at Tampere University Hospital, showcasing their dedication to improving pediatric health outcomes. Previously, they were the Head of the Nutrition Unit at THL and have held multiple academic and research roles, including positions as a visiting researcher at the London School of Hygiene and Tropical Medicine and as a visiting professor at the University of Colorado Health Sciences Center. Their international experience, combined with years of service in various national health councils and academic positions, highlights their multidisciplinary expertise and ability to lead significant research initiatives in nutrition, epidemiology, and public health.

 

Research Interests

The candidate’s research interests focus on the intersection of nutrition, epidemiology, and public health, with a strong emphasis on understanding the role of diet in the prevention and development of chronic diseases, particularly type 1 diabetes and autoimmune conditions. They have led numerous large-scale, longitudinal studies that explore how dietary patterns, early nutrition, and environmental factors influence disease risk from childhood through adulthood. Their work aims to identify critical dietary determinants of health, unraveling complex interactions between genetics, immune response, and lifestyle factors. The candidate’s research also extends to nutritional epidemiology, investigating the impact of maternal and infant nutrition on long-term health outcomes. Through participation in international consortia and collaborations, they have contributed significantly to advancing scientific knowledge on immune-mediated diseases and dietary interventions. Their ultimate goal is to inform public health policies and develop evidence-based dietary guidelines that promote disease prevention and enhance the quality of life across populations.

 

Research Skills

The candidate demonstrates exceptional research skills characterized by a robust blend of scientific rigor, leadership, and multidisciplinary collaboration. As a Research Professor at the Finnish Institute for Health and Welfare, they lead innovative studies that address critical public health challenges, particularly in the fields of nutrition and epidemiology. Their expertise is further showcased by their involvement in international projects, such as the EU-consortium Zero Hidden Hunger and national nutrition monitoring initiatives, where they serve as a principal investigator. The candidate’s prolific publication record in high-impact journals underscores their ability to produce meaningful, data-driven insights that influence the scientific community and public health policies. They have consistently contributed to groundbreaking research on the relationship between diet and chronic diseases, including type 1 diabetes, through methodologically sound studies. Their ability to manage complex research projects and guide multidisciplinary teams highlights their outstanding research skills and commitment to advancing scientific knowledge for societal benefit.

 

Award And Recognition 

The candidate’s outstanding contributions to nutrition and epidemiological research have earned them significant recognition within the scientific community. As a Research Professor at the Finnish Institute for Health and Welfare and a Professor of Epidemiology at Tampere University, they have led pioneering studies that address critical public health issues, including dietary impacts on autoimmune diseases. Their work has been published extensively in high-impact journals, and they are regularly invited to contribute to key international research collaborations, such as the EU-consortium Zero Hidden Hunger. They have played pivotal roles as principal investigator and committee member in numerous landmark studies, demonstrating exceptional leadership and expertise. The candidate’s dedication to advancing the fields of nutrition and public health has not only influenced policy but also improved health outcomes globally. Their achievements reflect a distinguished career marked by impactful research, academic leadership, and a commitment to enhancing the well-being of populations worldwide.

 

Conclusion

Based on the candidate’s comprehensive qualifications and achievements, they are highly deserving of the Best Researcher Award. With an extensive educational background that includes an MD and PhD from the University of Helsinki, the candidate has built a robust foundation in medical and research expertise. Their professional experience spans multiple high-impact roles, including Research Professor at the Finnish Institute for Health and Welfare and Professor of Epidemiology at Tampere University. They have demonstrated exceptional leadership in numerous significant research projects, such as the EU-consortium Zero Hidden Hunger and national nutrition monitoring programs. The candidate’s prolific publication record in top-tier journals, particularly on diet and autoimmune diseases like type 1 diabetes, highlights their contribution to advancing public health knowledge. Their multidisciplinary expertise, international collaborations, and commitment to impactful research establish them as a leading figure in their field, making them an outstanding candidate for this award.

 

Publication Top Notes

  1. Title: Early-pregnancy BMI, maternal gestational weight gain, and asthma and allergic diseases in children
    Authors: Ojwang’, V., Nwaru, B.I., Hanna-Mari, T., … Knip, M., Virtanen, S.M.
    Journal: Pediatric Allergy and Immunology
    Year: 2024
    Citations: 0
  2. Title: High Concentrations of Immunoglobulin G Against Cow Milk Proteins and Frequency of Cow Milk Consumption Are Associated With the Development of Islet Autoimmunity and Type 1 Diabetes—The Trial to Reduce Insulin-dependent Diabetes Mellitus (IDDM) in the Genetically at Risk (TRIGR) Study
    Authors: Niinistö, S., Cuthbertson, D., Miettinen, M.E., … Savilahti, E., Virtanen, S.M.
    Journal: Journal of Nutrition
    Year: 2024
    Citations: 0
  3. Title: Maternal gluten, cereal, and dietary fiber intake during pregnancy and lactation and the risk of islet autoimmunity and type 1 diabetes in the child
    Authors: Hakola, L., Lund-Blix, N.A., Takkinen, H.-M., … Aki, S., Marja, R.
    Journal: Clinical Nutrition ESPEN
    Year: 2024
    Citations: 0
  4. Title: Gut Inflammation Markers, Diet, and Risk of Islet Autoimmunity in Finnish Children – A Nested Case-Control Study
    Authors: Salo, T.E., Hakola, L., Niinistö, S., … Knip, M., Virtanen, S.M.
    Journal: Journal of Nutrition
    Year: 2024
    Citations: 0
  5. Title: Serum proteomics of mother-infant dyads carrying HLA-conferred type 1 diabetes risk
    Authors: Bhosale, S.D., Moulder, R., Suomi, T., … Knip, M., Lahesmaa, R.
    Journal: iScience
    Year: 2024
    Citations: 0
  6. Title: Intake of B vitamins and the risk of developing islet autoimmunity and type 1 diabetes in the TEDDY study
    Authors: Hakola, L., Mramba, L.K., Uusitalo, U., … Norris, J.M., Virtanen, S.M.
    Journal: European Journal of Nutrition
    Year: 2024
    Citations: 1
  7. Title: Detecting potential outliers in longitudinal data with time-dependent covariates
    Authors: Mramba, L.K., Liu, X., Lynch, K.F., … Uusitalo, U.M., Krischer, J.P.
    Journal: European Journal of Clinical Nutrition
    Year: 2024
    Citations: 3
  8. Title: Fruit, berry, and vegetable consumption and the risk of islet autoimmunity and type 1 diabetes in children—the Type 1 Diabetes Prediction and Prevention birth cohort study
    Authors: Mattila, M., Takkinen, H.-M., Peltonen, E.J., … Knip, M., Virtanen, S.M.
    Journal: American Journal of Clinical Nutrition
    Year: 2024
    Citations: 1
  9. Title: How prices and income influence global patterns in saturated fat intake by age, sex and world region: a cross-sectional analysis of 160 countries
    Authors: Ahles, A., Muhammad, A., Yenerall, J.N., … Siamusantu, W., Brown, K.
    Journal: BMJ Open
    Year: 2024
    Citations: 0
  10. Title: Periodic mobile application (eMOM) with self-tracking of glucose and lifestyle improves treatment of diet-controlled gestational diabetes without human guidance: a randomized controlled trial
    Authors: Kytö, M., Hotta, S., Niinistö, S., … Heihonen, S., Koivusalo, S.B.
    Journal: American Journal of Obstetrics and Gynecology
    Year: 2024
    Citations: 0